Akt-mediated phosphorylation of hsp70 regulates mitochondrial localization of SOD2 and oxidative stress in pulmonary artery endothelial cells during postnatal transition

Akt 介导的 hsp70 磷酸化调节出生后过渡期间肺动脉内皮细胞中 SOD2 的线粒体定位和氧化应激

基本信息

  • 批准号:
    10402122
  • 负责人:
  • 金额:
    $ 4.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2022-01-09
  • 项目状态:
    已结题

项目摘要

Project Summary Pulmonary circulation undergoes adaptive processes critical for survival of the newborn at birth. For a successful postnatal transition, several events come to play, including increased pulmonary blood flow and remodeling of muscularized small-medium size pulmonary arteries (PAs). One important mechanism regulating these processes is the activation of adaptive processes that regulate mitochondrial oxidative stress. However, the mechanism is unknown. For the past five years, through the mentored career development award, we have been exploring the molecular processes that maintain the activity of mitochondrial-localized superoxide dismutase (SOD2) appropriate for ROS levels in mitochondria during postnatal transition. Our findings demonstrate that phosphorylation of heat shock protein-70 (hsp70), a major cytosolic molecular chaperone is a critical mechanism regulating mitochondrial oxidative stress during exposure of the fetal lungs to high oxygen environment. We found that elevated ROS induces the activation of protein kinase-B (AKT1), which in turn phosphorylates Hsp70 on Serine-(S631) to promote the import of SOD2 into the mitochondria in response to stress. We also found that when phosphorylated on S631, Hsp70 recruits Obg-like ATPase-1 (OLA1) to Hsp70-SOD2 complexes and the binding of OLA1 drives the mitochondrial SOD2 import by antagonizing CHIP-mediated ubiquitination and proteasomal degradation of Hsp70 and its downstream target, SOD2. Disruption of AKT-mediated phosphorylation of Hsp70S631 increases mitochondrial ROS levels. We also observed that AKT activity is significantly decreased in persistent pulmonary hypertension of the newborn (PPHN) and contributes to impaired vasorelaxation in the disease. However, all these studies were done in vitro, therefore it is important to verify this critical mechanism in vivo. Our working hypothesis is that dynamic phosphorylation of Hsp70S631 by AKT is a novel mechanism promoting postnatal adaptation of pulmonary circulation at birth through mechanisms regulating mitochondrial import of SOD2 and redox balance. To test this hypothesis in an in vivo model, we will test the effect of disrupting OLA1 binding to hsp70 or AKT-mediated phosphorylation of Hsp70 in vivo using Sprague Dawley (SD) rats. We have generated a series of cell-permeable decoy peptide inhibitors of AKT and OLA1. For this, 4 weeks old rats will be treated with GSG (Akt inhibitor), or GLGIV (OLA1 inhibitor) peptide for 4 weeks in normoxic conditions. Echocardiographic measurements of tricuspid regurgitant jets (TR jets) and cardiac function will be performed. We will also quantify mitochondrial ROS levels using mitoSOX staining and HPLC. Vasorelaxation responses of PA in the treated and untreated groups to physiological stimuli in an ex-vivo preparations will be determined. It is anticipated that interruptions of hsp70 interactions with Akt or OLA1 will induce vascular remodeling and PPHN. While CHIP inhibition would increase vasorelaxation response of PAs to stimuli. Thus, increasing AKT activity may be a potential therapeutic option in the treatment of PPHN.
项目摘要 肺循环经历对新生儿生存至关重要的自适应过程。成功 产后过渡,发生了几次事件,包括增加的肺血流和重塑 肌肉发达的小中型肺动脉(PAS)。调节这些的一种重要机制 过程是调节线粒体氧化应激的自适应过程的激活。但是, 机制是未知的。在过去的五年中,通过指导的职业发展奖,我们一直 探索维持线粒体 - 定位超氧化物歧化酶活性的分子过程 (SOD2)适用于产后过渡期间线粒体中的ROS水平。我们的发现表明 热休克蛋白-70(HSP70)的磷酸化,主要的胞质分子伴侣是关键机制 在胎儿肺暴露于高氧气环境中,调节线粒体氧化应激。我们 发现升高的ROS诱导蛋白激酶-B的激活(AKT1),进而磷酸化HSP70 在丝氨酸(S631)上,促进SOD2响应压力而将SOD2进口到线粒体中。我们还发现 当在S631上磷酸化时,HSP70将OBG样ATPase-1(OLA1)募集到HSP70-SOD2复合物和 OLA1的结合通过对抗芯片介导的泛素化和 HSP70及其下游靶标SOD2的蛋白酶体降解。 AKT介导的破坏 HSP70S631的磷酸化增加了线粒体ROS水平。我们还观察到Akt活动是 新生儿(PPHN)的持续性肺动脉高压显着降低,并有助于受损 该疾病中的血管延缓。但是,所有这些研究都是在体外进行的,因此验证这一点很重要 体内关键机制。我们的工作假设是,Akt对HSP70S631的动态磷酸化是一个 通过机制促进出生时肺循环后出生后适应的新机制 调节SOD2和氧化还原平衡的线粒体导入。为了在体内模型中检验这一假设,我们将 测试使用使用HSP70与HSP70在体内使用HSP70结合或Akt介导的磷酸化的效果 Sprague Dawley(SD)大鼠。我们已经产生了一系列可渗透的诱饵肽抑制剂,Akt和 OLA1。为此,将用GSG(AKT抑制剂)或GLGIV(OLA1抑制剂)肽治疗4周大的大鼠,为4 数周在常氧条件下。三尖瓣反流喷气机(TR Jets)和的超声心动图测量 将执行心脏功能。我们还将使用有线染色和 HPLC。 PA在经过治疗和未处理的基团对前体内的生理刺激中的血管瘤反应 准备工作将确定。预计HSP70与AKT或OLA1的相互作用的中断会 诱导血管重塑和PPHN。而芯片抑制会增加PAS的血管结算反应 刺激。因此,增加AKT活性可能是PPHN治疗的潜在治疗选择。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Redox Signaling and Persistent Pulmonary Hypertension of the Newborn.
OLA1 Phosphorylation Governs the Mitochondrial Bioenergetic Function of Pulmonary Vascular Cells.
OLA1 磷酸化控制肺血管细胞的线粒体生物能功能。
  • DOI:
    10.1165/rcmb.2022-0186oc
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Sidlowski,Paul;Czerwinski,Amanda;Liu,Yong;Liu,Pengyuan;Teng,Ru-Jeng;Kumar,Suresh;Wells,Clive;PritchardJr,Kirkwood;Konduri,GirijaG;Afolayan,AdeleyeJ
  • 通讯作者:
    Afolayan,AdeleyeJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adeleye J afolayan其他文献

Adeleye J afolayan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adeleye J afolayan', 18)}}的其他基金

Akt-mediated phosphorylation of hsp70 regulates mitochondrial localization of SOD2 and oxidative stress in pulmonary artery endothelial cells during postnatal transition
Akt 介导的 hsp70 磷酸化调节出生后过渡期间肺动脉内皮细胞中 SOD2 的线粒体定位和氧化应激
  • 批准号:
    9981796
  • 财政年份:
    2016
  • 资助金额:
    $ 4.13万
  • 项目类别:
Akt-mediated phosphorylation of hsp70 regulates mitochondrial localization of SOD2 and oxidative stress in pulmonary artery endothelial cells during postnatal transition
Akt 介导的 hsp70 磷酸化调节出生后过渡期间肺动脉内皮细胞中 SOD2 的线粒体定位和氧化应激
  • 批准号:
    9750015
  • 财政年份:
    2016
  • 资助金额:
    $ 4.13万
  • 项目类别:
Akt-mediated phosphorylation of hsp70 regulates mitochondrial localization of SOD2 and oxidative stress in pulmonary artery endothelial cells during postnatal transition
Akt 介导的 hsp70 磷酸化调节出生后过渡期间肺动脉内皮细胞中 SOD2 的线粒体定位和氧化应激
  • 批准号:
    9162675
  • 财政年份:
    2016
  • 资助金额:
    $ 4.13万
  • 项目类别:

相似海外基金

Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
  • 批准号:
    10508305
  • 财政年份:
    2023
  • 资助金额:
    $ 4.13万
  • 项目类别:
An actionable secretory program that drives tumor progression in a genetically defined subset of lung squamous carcinoma
一种可操作的分泌程序,可驱动基因定义的肺鳞癌亚群中的肿瘤进展
  • 批准号:
    10646979
  • 财政年份:
    2023
  • 资助金额:
    $ 4.13万
  • 项目类别:
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
  • 批准号:
    10735778
  • 财政年份:
    2023
  • 资助金额:
    $ 4.13万
  • 项目类别:
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr
SMC1A/3粘连蛋白复合物介导的未整合HIV-1 DNA的沉默和Vpr的拮抗作用
  • 批准号:
    10760648
  • 财政年份:
    2023
  • 资助金额:
    $ 4.13万
  • 项目类别:
Targeting Myosin to Treat Polycystic Kidney Disease
靶向肌球蛋白治疗多囊肾
  • 批准号:
    10699859
  • 财政年份:
    2023
  • 资助金额:
    $ 4.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了